| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |